130 related articles for article (PubMed ID: 8173524)
1. Transforming growth factor-beta in tegumentary leishmaniasis.
Barral-Netto M; Barral A
Braz J Med Biol Res; 1994 Jan; 27(1):1-9. PubMed ID: 8173524
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism.
Barral-Netto M; Barral A; Brownell CE; Skeiky YA; Ellingsworth LR; Twardzik DR; Reed SG
Science; 1992 Jul; 257(5069):545-8. PubMed ID: 1636092
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta in human cutaneous leishmaniasis.
Barral A; Teixeira M; Reis P; Vinhas V; Costa J; Lessa H; Bittencourt AL; Reed S; Carvalho EM; Barral-Netto M
Am J Pathol; 1995 Oct; 147(4):947-54. PubMed ID: 7573370
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis.
Barral A; Barral-Netto M; Yong EC; Brownell CE; Twardzik DR; Reed SG
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3442-6. PubMed ID: 7682701
[TBL] [Abstract][Full Text] [Related]
5. Anti-TGF-beta treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production.
Li J; Hunter CA; Farrell JP
J Immunol; 1999 Jan; 162(2):974-9. PubMed ID: 9916722
[TBL] [Abstract][Full Text] [Related]
6. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
7. Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages.
Gantt KR; Schultz-Cherry S; Rodriguez N; Jeronimo SM; Nascimento ET; Goldman TL; Recker TJ; Miller MA; Wilson ME
J Immunol; 2003 Mar; 170(5):2613-20. PubMed ID: 12594289
[TBL] [Abstract][Full Text] [Related]
8. [Immunopathology of American tegumentary leishmaniasis].
Castés M; Tapia FJ
Acta Cient Venez; 1998; 49(1):42-56. PubMed ID: 10205916
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta and Th17 responses in resistance to primary murine schistosomiasis mansoni.
Tallima H; Salah M; Guirguis FR; El Ridi R
Cytokine; 2009 Dec; 48(3):239-45. PubMed ID: 19717308
[TBL] [Abstract][Full Text] [Related]
10. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
Sadick MD; Locksley RM; Tubbs C; Raff HV
J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
[TBL] [Abstract][Full Text] [Related]
11. Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses.
Srivastava S; Pandey SP; Jha MK; Chandel HS; Saha B
Clin Exp Immunol; 2013 Jun; 172(3):403-9. PubMed ID: 23600828
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii.
Hunter CA; Bermudez L; Beernink H; Waegell W; Remington JS
Eur J Immunol; 1995 Apr; 25(4):994-1000. PubMed ID: 7737303
[TBL] [Abstract][Full Text] [Related]
13. The importance of TGF-beta in murine visceral leishmaniasis.
Wilson ME; Young BM; Davidson BL; Mente KA; McGowan SE
J Immunol; 1998 Dec; 161(11):6148-55. PubMed ID: 9834100
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta-associated enhanced susceptibility to leishmaniasis following intramuscular vaccination of mice with Leishmania amazonensis antigens.
Pinheiro RO; Pinto EF; Lopes JR; Guedes HL; Fentanes RF; Rossi-Bergmann B
Microbes Infect; 2005 Oct; 7(13):1317-23. PubMed ID: 16027022
[TBL] [Abstract][Full Text] [Related]
15. Host susceptibility factors to cutaneous leishmaniasis.
Jones DE; Elloso MM; Scott P
Front Biosci; 1998 Nov; 3():D1171-80. PubMed ID: 9820738
[TBL] [Abstract][Full Text] [Related]
16. Exacerbation of Leishmania (Viannia) shawi infection in BALB/c mice after immunization with soluble antigen from amastigote forms.
Passero LF; Da Costa Bordon ML; De Carvalho AK; Martins LM; Corbett CE; Laurenti MD
APMIS; 2010 Dec; 118(12):973-81. PubMed ID: 21091779
[TBL] [Abstract][Full Text] [Related]
17. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major.
Mbow ML; Bleyenberg JA; Hall LR; Titus RG
J Immunol; 1998 Nov; 161(10):5571-7. PubMed ID: 9820534
[TBL] [Abstract][Full Text] [Related]
18. Regulator and effector functions of T-cell subsets in human Leishmania infections.
Kemp M
APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493
[TBL] [Abstract][Full Text] [Related]
19. Immunological factors governing resistance and susceptibility of mice to Leishmania major infection.
Aguilar-Torrentera F; Carlier Y
Rev Latinoam Microbiol; 2001; 43(3):135-42. PubMed ID: 17061500
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
Scott P
J Immunol; 1991 Nov; 147(9):3149-55. PubMed ID: 1833466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
